Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Michigan
About this trial
To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of blindness: glaucoma, diabetic retinopathy, and visually significant cataract.
Eligibility criteria
Qualifiers
None
Disqualifiers
significant eye pain
sudden decrease in vision within one week
binocular diplopia
cognitive impairment
Trial design
Treatments tested in this trial
- Standard optometric examination
- Technology enhanced eye disease detection protocol
Treatment groups
900 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Michigan
Lead sponsor
Centers for Disease Control and Prevention
Collaborator
Source ClinicalTrials.gov